Hennion & Walsh Asset Management’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-423,392
Closed -$631K 896
2024
Q3
$631K Sell
423,392
-44,463
-10% -$66K 0.03% 564
2024
Q2
$585K Sell
467,855
-308,165
-40% -$400K 0.03% 544
2024
Q1
$931K Buy
776,020
+79,525
+11% +$79.6K 0.05% 439
2023
Q4
$1.05M Buy
696,495
+28,975
+4% +$41.9K 0.06% 392
2023
Q3
$1.07M Buy
667,520
+40,100
+6% +$73K 0.07% 345
2023
Q2
$1.36M Buy
627,420
+1,170
+0.2% +$1.83K 0.08% 302
2023
Q1
$914K Buy
626,250
+56,740
+10% +$73K 0.06% 377
2022
Q4
$712K Buy
569,510
+347,559
+157% +$548K 0.04% 410
2022
Q3
$419K Buy
221,951
+55,248
+33% +$131K 0.03% 523
2022
Q2
$422K Sell
166,703
-635,271
-79% -$1.85M 0.03% 524
2022
Q1
$2.76M Sell
801,974
-40,352
-5% -$143K 0.15% 182
2021
Q4
$4.05M Sell
842,326
-769,741
-48% -$3.12M 0.2% 137
2021
Q3
$5.88M Sell
1,612,067
-75,255
-4% -$280K 0.31% 79
2021
Q2
$6.83M Buy
1,687,322
+36,905
+2% +$145K 0.36% 63
2021
Q1
$7.08M Buy
+1,650,417
New +$7.88M 0.43% 48

Other funds holding OPK

Hennion & Walsh Asset Management's OPK Position: Q4 2024 in Review

Hennion & Walsh Asset Management sold out of Opko Health (OPK) in Q4 2024, closing a stake of 423,392 shares — an estimated $631K sold.

Hennion & Walsh Asset Management first reported a position in OPK in Q1 2021 and held it in 15 quarters. The position peaked at $7.08M in Q1 2021. 235 funds tracked by Wall St. Rank hold OPK as of Q4 2024.

  • Hennion & Walsh Asset Management reported no remaining Opko Health position as of Q4 2024 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 423,392 Opko Health shares in Q4 2024, an estimated $631K.
  • Hennion & Walsh Asset Management first reported a position in Opko Health in Q1 2021 and held it in 15 quarters.
  • Hennion & Walsh Asset Management's Opko Health position peaked at $7.08M in Q1 2021.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q4 2024.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2024, filed 15 Jan 2025.